Fail Safe Cell Therapy


Rapid isolation of bone marrow mesenchymal stromal cells using integrated centrifuge-based technology

Amanda M Meppelink, Xing-Hua Wang, Gino Bradica, Kathryn Barron, Kathleen Hiltz, Xiang-Hong Liu, Scott M Goldman, Joseph P Vacanti, Armand Keating, David M Hoganson
Cytotherapy 2016 Jun;18(6):729-39

The use of bone marrow–derived mesenchymal stromal cells (MSCs) in cell-based therapies is currently being developed for a number of diseases. Thus far, the clinical results have been inconclusive and variable, in part because of the variety of cell isolation procedures and culture conditions used in each study. A new isolation technique that streamlines the method of concentration and demands less time and attention could provide clinical and economic advantages compared with current methodologies…


Sorry, comments are closed for this post.